|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 491/22 | |
| A61K 31/4745 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3094635 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15700474.8 |
| Europos patento paraiškos padavimo data | 2015-01-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-11-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/050728 |
| Data | 2015-01-16 |
| (87) | Numeris | WO 2015/107131 |
| Data | 2015-07-23 |
| (30) | Numeris | Data | Šalis |
| 14151688 | 2014-01-17 | EP |
| (72) |
H JGAARD, Bent, DK
|
| (73) |
Oncoral Pharma ApS,
Energivej 42, 2750 Ballerup,
DK
|
| (54) | SOLID ORAL DOSAGE FORM OF IRINOTECAN FOR THE TREATMENT OF CANCER |
| SOLID ORAL DOSAGE FORM OF IRINOTECAN FOR THE TREATMENT OF CANCER |